“Intravenous Immunoglobulin Costs Are Higher for off-Label Indications in a High-Complexity Hospital in Colombia”. Universitas Medica 64, no. 4 (January 24, 2024). Accessed October 23, 2025. https://revistas.javeriana.edu.co/index.php/vnimedica/article/view/36867.